Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Sage Therapeutics Inc (SAGE)

  • Event
  • Aug. 02, 2022, 10:45 UTC
  • 13
  • 1 comments

(10% Negative) Sage Therapeutics, Inc. (SAGE) Reports Q3 2022 Financial Results

Comment Full text

Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL)

  • Event
  • Aug. 02, 2022, 10:10 UTC
  • 10
  • 1 comments

(90% Positive) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Announces Clinical Development Update (Form 6-K)

Comment Full text

Rigel Pharmaceuticals Inc (RIGL)

  • Event
  • Aug. 02, 2022, 00:00 UTC
  • 23
  • 1 comments

(99% Positive) RIGEL PHARMACEUTICALS INC (RIGL) Reports 163% Profit Growth for 2022-06-30

Comment Full text

Sage Therapeutics Inc (SAGE)

  • Event
  • Aug. 02, 2022, 00:00 UTC
  • 19
  • 1 comments

(66% Neutral) Sage Therapeutics, Inc. (SAGE) Reports Net Loss for 2022-06-30

Comment Full text

Phathom Pharmaceuticals Inc (PHAT)

  • Event
  • Aug. 02, 2022, 00:00 UTC
  • 23
  • 1 comments

(61% Neutral) PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports Net Loss for 2022-06-30

Comment Full text

Esperion Therapeutics Inc (ESPR)

  • Event
  • Aug. 02, 2022, 00:00 UTC
  • 23
  • 1 comments

(42% Neutral) Esperion Therapeutics, Inc. (ESPR) Reports Net Loss for 2022-06-30

Comment Full text

Evolus Inc (EOLS)

  • Event
  • Aug. 02, 2022, 00:00 UTC
  • 21
  • 1 comments

(47% Neutral) EVOLUS, INC. (EOLS) Reports 75% Loss Increase for 2022-06-30

Comment Full text

Amicus Therapeutics Inc (FOLD)

  • Event
  • Aug. 01, 2022, 21:10 UTC
  • 13
  • 1 comments

(99% Neutral) AMICUS THERAPEUTICS, INC. (FOLD) Announces New Board Appointment

Comment Full text

Acumen Pharmaceuticals Inc (ABOS)

  • Event
  • Aug. 01, 2022, 21:06 UTC
  • 13
  • 1 comments

(99% Neutral) Acumen Pharmaceuticals, Inc. (ABOS) Provides Update on appear for Alzheimer’s disease (AD)

Comment Full text

Aclaris Therapeutics Inc (ACRS)

  • Event
  • Aug. 01, 2022, 20:45 UTC
  • 13
  • 1 comments

(99% Neutral) Aclaris Therapeutics, Inc. (ACRS) Announces New Board Appointment

Comment Full text
  • Previous
  • 142
  • 143
  • 144
  • 145
  • 146
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124506)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin